Cocrystal Pharma to Present at Barclays Global Healthcare Conference on Thursday, March 12

BOTHELL, WA and ATLANTA, GA -- (Marketwired) -- 03/03/15 -- Cocrystal Pharma, Inc. (OTCQB: COCP), a company focused on developing novel antiviral therapeutics for human diseases, announced today that it will present at the Barclays 2015 Global Healthcare Conference on Thursday, March 12, 2015 at 8:00 AM ET at Loews Miami Beach Hotel in Miami, Florida. Dr. Raymond F. Schinazi, co-chairman of the Board of Directors of Cocrystal Pharma, will be presenting on behalf of the Company.

A live webcast of the presentation can be accessed from the conference website at A replay of the webcast will be archived on the Cocrystal website shortly after the event.

About Cocrystal Pharma, Inc.
Cocrystal is a pharmaceutical company seeking to discover novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. Cocrystal employs unique technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. These technologies and our market-focused approach to drug discovery are designed to efficiently deliver small molecule therapeutics that are safe, effective and convenient to administer. Cocrystal has previously received strategic investments from Teva Pharmaceuticals, OPKO Health (NYSE: OPK), Dr. Raymond Schinazi, Brace Pharmaceutical, LLC, and The Frost Group. For further information about Cocrystal please refer to

   Contact: MDM Worldwide  David Zazoff212-643-0417

Source: Cocrystal Pharma, Inc.